Literature DB >> 381860

Comparison of metoprolol and pindolol in the treatment of mild to moderate hypertension: a double-blind crossover study.

J J McNeil, W J Louis, A E Doyle, F J Vajda.   

Abstract

Matched doses of metoprolol and pindolol were administered to 31 hypertensive outpatients in a double-blind randomized crossover trial, which was designed to compare the antihypertensive efficacy and pattern of side effects of the two drugs. Twenty-nine patients completed the study. A tenfold difference in dose (25 +/- 2 mg/day of pindolol and 234 +/- 22 mg/day of metoprolol) was required to produce a similar antihypertensive effect. There was a significantly greater fall in pulse rate during metoprolol treatment. Complaints of dry mouth, mild Raynaud's phenomenon, and eye discomfort were more frequent during treatment with metoprolol; and sleep disturbances and abnormal dreaming patterns were more frequent during treatment with pindolol.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381860     DOI: 10.5694/j.1326-5377.1979.tb127016.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  The effect of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on circadian heart rate.

Authors:  P Fitscha; B Tiso; W Meisner; D Spitzer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 2.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

3.  Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen.

Authors:  G Muiesan; E Agabiti-Rosei; A Carotti; L Corea; P Innocenti; C Montervino; R Prezioso; G Romanelli; M Toso; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.